Page last updated: 2024-08-23

epirubicin and Digestive System Neoplasms

epirubicin has been researched along with Digestive System Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fridrik, M; Hausmaninger, H; Hehenwarter, W; Lehnert, M; Manfreda, D; Samonigg, H; Schiller, L; Sevelda, P; Steger, G; Tschurtschenthaler, G1
Armand, JP; Evans, TR; Seymour, L1

Trials

2 trial(s) available for epirubicin and Digestive System Neoplasms

ArticleYear
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Epirubicin; Female; Humans; Middle Aged; Mitoxantrone; Remission Induction; Soft Tissue Neoplasms; Survival Analysis; Vindesine

1995
Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
    European journal of cancer (Oxford, England : 1990), 1999, Volume: 35 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Digestive System Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Mesothelioma; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Thiophenes; Treatment Outcome

1999